Post by Gilead Sciences

Today, we celebrate one year since the U.S. FDA’s approval of our innovative, twice-yearly HIV prevention medication, and the groundwork we’ve made globally since then to ensure access for those who need it most. In our pursuit to help end the epidemic, we know that if you don’t end the HIV epidemic everywhere, you don’t end it anywhere. Read more about the major milestones made since launch: https://gilead.inc/3QnISYl